Casgevy (exa-cel)

red blood cells
Biotech

Vertex and Orna team up to develop new blood disorder treatments

Vertex is hoping to build out its inherited blood disease portfolio, teaming up with Orna to develop next-gen gene therapies for SCD and TDT.
Gabrielle Masson Jan 7, 2025 7:00am
Graphic of an open door with the words exit above it

CRISPR Tx CMO resigns just 6 days after Casgevy's FDA approval

Dec 20, 2023 12:00pm